| Wang, Xiang Sean |
NCT04790305: Effect of Huaier Granule on Adjuvant Treatment for High-risk Early-stage Triple-negative Breast Cancer |
|
|
| Recruiting | 4 | 1072 | RoW | Huaier Granule, Z20000109（NMPA Approval Number） | Fudan University, LinkDoc Technology (Beijing) Co. Ltd., Huazhong University of Science and Technology | Carcinoma Breast, Triple-negative Breast Cancer, Invasive Ductal Carcinoma, Breast | 12/27 | 07/28 | | |
NCT06300177: D-1553 Tablet Versus Docetaxel Injection for KRAS G12C Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Standard Therapy Failure |
|
|
| Recruiting | 3 | 522 | RoW | D-1553 Tablet, Docetaxel injection | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Non Small Cell Lung Cancer | 10/26 | 12/27 | | |
TQB2450-AL2846-III-01, NCT05922345: Evaluation of the Efficacy and Safety of AL2846 Capsule Combined With TQB2450 Injection Compared to Docetaxel Injection in Advanced Non-small Cell Lung Cancer Patients Who Have Failed With Immunotherapy. |
|
|
| Recruiting | 3 | 518 | RoW | TQB2450 injection, docetaxel injection matching placebo, AL2846 capsules, TQB2450 placebo, docetaxel injection, AL2846 matching placebo | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Non-small Cell Lung Cancer | 08/25 | 12/25 | | |
NCT03351062: Efficacy of Tamoxifen Versus Toremifene in CYP2D6 IM/PM of Premenopausal Patients With ER-positive Early Breast Cancer |
|
|
| Recruiting | 3 | 844 | RoW | Tamoxifen, Tamoxifen citrate, Toremifene, fareston | Chinese Anti-Cancer Association, Fudan University, Henan Cancer Hospital, The First Hospital of Jilin University, Southwest Hospital, China, First Hospital of China Medical University, Guangdong Provincial People's Hospital, Harbin Medical University, First Affiliated Hospital of Chongqing Medical University, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Jiangsu Provincial People's Hospital, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Zhejiang Cancer Hospital, Tianjin Medical University Cancer Institute and Hospital, Union hospital of Fujian Medical University, Hebei Tumor Hospital, Hunan Cancer Hospital, Affiliated Hospital of Qinghai University, Wuhan TongJi Hospital, Hainan People's Hospital, The Third Affiliated Hospital of Kunming Medical College., The Third Affiliated Hospital of Nanchang University | Breast Cancer Female | 12/25 | 12/25 | | |
NCT03322969: Receiving Modified Chemotherapy Followed With Radical Resection After Neoadjuvant Chemotherapy |
|
|
| Recruiting | 2 | 60 | RoW | Paclitaxel/DDP, Group A, XELOX/SOX, Group B | Peking Union Medical College Hospital | Locally Advanced Gastric Cancer | 08/22 | 08/23 | | |
NCT04706598: Safety and Efficacy of Camrelizumab for High-risk NMIBC Failing BCG Treatment |
|
|
| Active, not recruiting | 1/2 | 25 | RoW | Camrelizumab, SHR-1210 | Fudan University, Shanghai Shen Kang Hospital Development Center | Urinary Bladder Neoplasms, Immunotherapy | 07/24 | 12/24 | | |
NCT04803851: Anlotinib Plus Anti-PD-1 Antibody AK105 for Advanced Pancreatic Cancer |
|
|
| Recruiting | 1/2 | 29 | RoW | Anlotinib plus AK105 | Peking Union Medical College Hospital | Anlotinib, Anti-PD-1 Antibody, Advanced Pancreatic Cancer | 02/24 | 06/24 | | |
KL264-01, NCT04152499: Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies |
|
|
| Recruiting | 1/2 | 1300 | Canada, US, RoW | SKB264 | Klus Pharma Inc. | Epithelial Ovarian Cancer, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Urothelial Carcinoma, Non-Small Cell Lung Cancer, Small-Cell Lung Cancer, Endometrial Carcinoma, Head and Neck Squamous Cell Carcinoma, Breast Cancer | 08/25 | 07/26 | | |
| Recruiting | 1/2 | 725 | RoW | JSKN003 | Jiangsu Alphamab Biopharmaceuticals Co., Ltd | Advanced Solid Tumor | 12/24 | 12/26 | | |
|
| Recruiting | 1/2 | 500 | Europe, Canada, Japan, US, RoW | Oral repotrectinib (TPX-0005), repotrectinib | Turning Point Therapeutics, Inc., Zai Lab (Shanghai) Co., Ltd. | Locally Advanced Solid Tumors, Metastatic Solid Tumors | 02/28 | 02/28 | | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NCT05143593: Species-specific Bacterial Detector for Fast Pathogen Diagnosis of Severe Pneumonia |
|
|
| Not yet recruiting | N/A | 256 | RoW | results of SSBD are used to guide antibiotics adjustment | Chinese Medical Association | Severe Pneumonia | 06/25 | 06/25 | | |
SURF, NCT06539689: A Trail of Sperstent® Used for Residual Lesions of Femoropopliteal Arteries |
|
|
| Recruiting | N/A | 240 | RoW | Sperstent® peripheral spot stent system, Everflex® self-expanding peripheral stent system | FrontAce Scientific Co., Ltd | Peripheral Arterial Disease, Stenosis, Dissection | 12/26 | 12/26 | | |
NCT06062927: Geno-radiomics Based Model for Evaluation of Immunotherapy and Targeted Therapy for Advanced Soft Tissue Sarcoma |
|
|
| Recruiting | N/A | 60 | RoW | | Peking Union Medical College Hospital | Advanced Soft Tissue Sarcoma | 02/26 | 02/27 | | |
| Yu, Chen |
NCT06552520: To Evaluate the Phase III Clinical Trial of TQH2722 Injection in the Treatment of Moderate to Severe Atopic Dermatitis |
|
|
| Not yet recruiting | 3 | 500 | RoW | TQH2722 injection, Placebo of TQH2722 injection | Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. | Atopic Dermatitis | 10/25 | 06/26 | | |
NCT05136456: Evaluate the Efficacy and Safety of SHR1459 Tablets in Patients With Primary Membranous Nephropathy |
|
|
| Active, not recruiting | 2 | 61 | RoW | SHR1459 Low Dose, SHR1459 High Dose, Placebo | Reistone Biopharma Company Limited | Primary Membranous Nephropathy | 08/23 | 03/24 | | |
| Recruiting | 2 | 140 | RoW | WS016 3g, WS016 6g, WS016 12g, Matching Placebo | Waterstone Pharmaceutical (Wuhan) Co., LTD. | Hyperkalemia | 04/24 | 08/24 | | |
NCT05970432: A Clinical Study of TQH2722 Injection in the Treatment of Moderate to Severe Atopic Dermatitis |
|
|
| Recruiting | 2 | 160 | RoW | TQH2722 injection 300mg-150mg, TQH2722 injection 600mg-300mg, TQH2722 injection 900mg-450mg, TQH2722 injection matching Placebo | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Atopic Dermatitis | 03/24 | 03/24 | | |
NCT04905602: A Trial of SHR-1905 in Healthy Subjects and Subjects With Mild Asthma |
|
|
| Completed | 1 | 86 | RoW | SHR-1905/placebo | Shanghai Hengrui Pharmaceutical Co., Ltd. | Asthma | 10/23 | 10/23 | | |
NCT05753033: The Pharmacokinetics (PK), Safety, Tolerability of SR750 in Healthy Volunteers |
|
|
| Completed | 1 | 56 | RoW | SR750 tablet, Placebo | Shanghai SIMR Biotechnology Co., Ltd. | Healthy | 09/23 | 09/23 | | |
NCT05895812: A Study in Subjects With Renal Impairment Compared to Subjects With Normal Renal Function |
|
|
| Completed | 1 | 24 | RoW | Deuremidevir Hydrobromide Tablets | Shanghai Vinnerna Biosciences Co., Ltd., Sponsor GmbH | Subjects With Renal Impairment, Healthy Subjects | 08/23 | 08/23 | | |
NCT06070857: Study of the Safety, Tolerability, and Pharmacokinetics of LV232 Capsules in Chinese Healthy Volunteers |
|
|
| Recruiting | 1 | 48 | RoW | LV232, Placebo | Vigonvita Life Sciences | Healthy Subjects | 12/24 | 12/24 | | |
NCT06279533: Safety and Pharmacokinetics Study of Multiple Ascending Doses and Food Effect of LV232 Capsules |
|
|
| Recruiting | 1 | 48 | RoW | LV232/Placebo, LV232 | Vigonvita Life Sciences | Healthy Subjects | 12/24 | 12/24 | | |
| Recruiting | N/A | 2500 | RoW | | Gang Wang, MD | Psoriasis Patients, COVID-19 | 05/23 | 07/23 | | |
MATCH, NCT04572568: Registry of Multimodality Treatment for Brain Arteriovenous Malformation in Mainland China |
|
|
| Recruiting | N/A | 2000 | RoW | Multi-disciplinary assessment | Beijing Tiantan Hospital, Beijing Neurosurgical Institute, Peking University International Hospital, West China Hospital, First Affiliated Hospital of Harbin Medical University, Sichuan Provincial People's Hospital, The First Hospital of Jilin University, Shanxi Provincial People's Hospital, The Second Hospital of Shandong University, The First Affiliated Hospital of Zhengzhou University, First Affiliated Hospital of Xinjiang Medical University, The General Hospital of Central Theater Command, The Affiliated Hospital Of Guizhou Medical University, First Affiliated Hospital of Guangxi Medical University, Tianjin Medical University Second Hospital, The First Affiliated Hospital of Shanxi Medical University, Shengjing Hospital, Second Affiliated Hospital of Guangzhou Medical University, Hainan People's Hospital, The Second Affiliated Hospital of Kunming Medical University, The Affiliated Hospital of Qingdao University, Second Xiangya Hospital of Central South University, Second Affiliated Hospital of Soochow University, General Hospital of Ningxia Medical University, Second Hospital of Lanzhou University, The First Affiliated Hospital of Anhui Medical University, First Affiliated Hospital of Zhejiang University, Qilu Hospital of Shandong University, Jining Medical University, First Affiliated Hospital of Chongqing Medical University, First Affiliated Hospital of Fujian Medical University, Shandong Provincial Hospital, The Affiliated Hospital of Xuzhou Medical University, Henan Provincial People's Hospital, Binzhou Medical University, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Brain Arteriovenous Malformation | 04/32 | 04/33 | | |
| Liu, Na |
NCT04859621: Phase II Clinical Trial of Vitamin D3 for Reducing Recurrence of Recurrent Lower Urinary Tract Infections |
|
|
| Recruiting | 2 | 150 | RoW | Vitamin D3 4000 IU, Vitamin D3 2000 IU, Placebo, standard antibiotic therapy | Zensun Sci. & Tech. Co., Ltd. | Recurrent Urinary Tract Infection | 04/25 | 07/25 | | |
NCT04668534: Effect of Transcutaneous Auricular Vagal Nerve Stimulation on Functional Dyspepsia |
|
|
| Recruiting | N/A | 300 | RoW | taVNS 10, taVNS 25, Control | Air Force Military Medical University, China | Functional Dyspepsia | 12/21 | 03/22 | | |
NCT05513040: Clinical Course of Functional Dyspepsia and Factors Predicting Outcome in Patients Receiving Medication-based Treatment |
|
|
| Recruiting | N/A | 300 | RoW | | Air Force Military Medical University, China | Functional Dyspepsia | 03/25 | 06/25 | | |
NCT05503940: Association of Multiple Medications With the Severity of Dyspepsia |
|
|
| Recruiting | N/A | 600 | RoW | | Air Force Military Medical University, China | Dyspepsia | 12/23 | 06/24 | | |
NCT06756139: Effects of Cognitive Behavioral Therapy Through a Mobile App on Patients With Refractory Functional Dyspepsia |
|
|
| Recruiting | N/A | 88 | RoW | cognitive behavioural therapy mobile application, Flupentixol and Melitracen Tablets | Air Force Military Medical University, China, Xi'an 986 Hospital, Shaanxi Second People's Hospital, Xi'an People's Hospital (Xi'an Fourth Hospital), Tang-Du Hospital, Hainan People's Hospital | Functional Dyspepsia, Self-help Mobile Cognitive Behavioral Therapy, Antipsychotic Drug | 11/25 | 11/25 | | |
| Recruiting | N/A | 500 | RoW | ALF, SALF, ACLF | First Affiliated Hospital Xi'an Jiaotong University | Liver Failure | 12/24 | 12/28 | | |
NCT05841225: the Relationship Between Executive Function and Diet Adherence in Patients With Type 2 Diabetes Mellitus |
|
|
| Not yet recruiting | N/A | 436 | NA | Food-related inhibitory control training based on computer, Non-food-related inhibitory control training based on computer | Na Liu | Type 2 Diabetes Mellitus | 12/24 | 12/25 | | |
NCT05527496: Effect of Hp Infection on the Quality of Gastric Mucosa Preparation |
|
|
| Recruiting | N/A | 200 | RoW | | Second Affiliated Hospital of Xi'an Jiaotong University | Helicobacter Pylori Infection | 08/23 | 08/23 | | |
NCT05524675: The Effect of Multiple Medications on the Incidence of Organic Dyspepsia |
|
|
| Recruiting | N/A | 500 | RoW | | Air Force Military Medical University, China | Dyspepsia | 12/23 | 06/24 | | |
